Creative Biolabs ADC Blog

Menu

Skip to content
  • Home
  • Antibody-drug Conjugates Research
  • Antibody-drug Conjugates Manufacturing
  • News

Monthly Archives: November 2020

30Nov/20

Analysis of the ADCs Drugs Approved by FDA

November 30, 2020ReviewADC, CD30, FDA ADCsbioadc

Antibody-drug conjugate (ADC) has achieved great progress in the past decade. So far, ten ADC drugs have been approved by the FDA, of which five were approved in 2019 and 2020, andRead More…

Categories

Recent Posts

  • The Renaissance of “Magic Bullets”: Navigating the Complex Landscape of Next-Generation ADC Development
  • The Era of the “Biological Missile”: Innovations and Frontiers in Antibody-Drug Conjugate Development
  • Targeting Drug-Resistant Breast Cancer with a Novel ADC
  • Aptamer-Drug Conjugates: The Next Frontier in Targeted Cancer Therapy Shows Encouraging Results
  • A New Hope for Cancer Therapy: How ADCs are Redefining Treatment

Archives

Contact Us

USA - UK

Copyright © Creative Biolabs ADC Blog
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Home
  • Antibody-drug Conjugates Research
  • Antibody-drug Conjugates Manufacturing
  • News